Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study
0Citations signalées
34Institutions associées
15Pays d’affiliation
Résumé fourni par la source
This comparative effectiveness research study investigates whether adjuvant chemotherapy is associated with survival in patients with gynecologic cancer undergoing pelvic exenteration with pelvic lymph node metastasis.
Institutions
Università Cattolica del Sacro CuoreAgostino Gemelli University PolyclinicNational Institute of OncologyInstitut universitaire du cancer de Toulouse OncopoleUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu MureșIstituti di Ricovero e Cura a Carattere ScientificoUniversitat de ValènciaHospital Universitari i Politècnic La FeIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Başkent University HospitalCharles UniversityGeneral University Hospital in PragueKarolinska University HospitalKarolinska InstitutetHumboldt-Universität zu BerlinBerlin Institute of Health at Charité - Universitätsmedizin BerlinCharité - Universitätsmedizin BerlinQueen Elizabeth HospitalUniversidad de NavarraHospital Universitario La PazNightingale HospitalNational Cancer InstituteN.N. Alexandrov National Cancer CentreGhent University HospitalGhent UniversityKoç UniversityIstanbul University-CerrahpaşaIstanbul UniversityNational Institute of Cardiovascular DiseasesUniversity of UdineOspedale Santa Maria della Misericordia di UdineInsermCentre de Recherches en Cancérologie de ToulouseUniversidad Cardenal Herrera CEU
Sujets associés
Endometrial and Cervical Cancer TreatmentsColorectal Cancer Surgical TreatmentsOvarian cancer diagnosis and treatment